Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Annette S Kim, Ph.D., M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Aziz-Bose R, Wachter F, Chiarle R, Lindeman NI, Kim AS, Degar BA, Davies K, Pikman Y. Rapid next-generation sequencing aids in diagnosis of transient abnormal myelopoiesis in a phenotypically normal newborn. Blood Adv. 2022 May 10; 6(9):2893-2896. PMID: 35090166.
    Citations:    Fields:    
  2. Pollard J, Furutani E, Liu S, Esrick EB, Cohen LE, Bledsoe JR, Liu CW, Lu K, Ramírez MJ, Surrallés J, Malsch MM, Kuniholm A, Galvin A, Armant M, Kim AS, Ballotti K, Moreau LA, Zhou Y, Babushok DV, Boulad F, Carroll C, Hartung H, Hont A, Nakano TA, Olson TS, Sze SK, Thompson AA, Wlodarski MW, Gu X, Libermann TA, D'Andrea AD, Grompe MCP, Weller E, Shimamura A. Metformin for Treatment of Cytopenias in Children and Young Adults with Fanconi Anemia. Blood Adv. 2022 May 02. PMID: 35500223.
    Citations:    Fields:    
  3. Nardi V, Tsuchiya KD, Kim AS, Bean LJH, Halley JG, Long TA, Szelinger S, Vasalos P, Thorson JA, Moyer AM, Moncur JT. Next-Generation Sequencing Somatic and Germline Assay Troubleshooting Guide Derived From Proficiency Testing Data. Arch Pathol Lab Med. 2022 04 01; 146(4):451-461. PMID: 34424952.
    Citations:    Fields:    Translation:HumansCells
  4. Kim AS, Pozdnyakova O. SOHO State of the Art Updates and Next Questions | Myeloid/Lymphoid Neoplasms with Eosinophilia and Gene Rearrangements: Diagnostic Pearls and Pitfalls. Clin Lymphoma Myeloma Leuk. 2022 Mar 19. PMID: 35478091.
    Citations:    Fields:    
  5. Bruehl FK, Kim AS, Li MM, Lindeman NI, Moncur JT, Souers RJ, Vasalos P, Voelkerding KV, Xian RR, Surrey LF. Tiered Somatic Variant Classification Adoption Has Increased Worldwide With Some Practice Differences Based on Location and Institutional Setting. Arch Pathol Lab Med. 2022 01 03. PMID: 34979564.
    Citations:    Fields:    
  6. Garcia JS, Kim HT, Murdock HM, Cutler CS, Brock J, Gooptu M, Ho VT, Koreth J, Nikiforow S, Romee R, Shapiro R, Loschi F, Ryan J, Fell G, Karp HQ, Lucas F, Kim AS, Potter D, Mashaka T, Stone RM, DeAngelo DJ, Letai A, Lindsley RC, Soiffer RJ, Antin JH. Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active. Blood Adv. 2021 12 28; 5(24):5536-5545. PMID: 34614506.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  7. Zhang BM, Keegan A, Li P, Lindeman NI, Nagarajan R, Routbort MJ, Vasalos P, Kim AS, Merker JD. An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies. Arch Pathol Lab Med. 2021 09 01; 145(9):1110-1116. PMID: 33450747.
    Citations:    Fields:    Translation:Humans
  8. Sadigh S, Kim AS. Molecular Pathology of Myeloid Neoplasms: Molecular Pattern Recognition. Surg Pathol Clin. 2021 Sep; 14(3):517-528. PMID: 34373100.
    Citations:    Fields:    Translation:Humans
  9. Wang SA, Ok CY, Kim AS, Lucas F, Morgan EA, Thakral B, Patel S, Nardi V, Patel KM, Weinberg OK, Hasserjian RP. Myelodysplastic syndromes with no somatic mutations detected by next-generation sequencing display similar features to myelodysplastic syndromes with detectable mutations. Am J Hematol. 2021 11 01; 96(11):E420-E423. PMID: 34416041.
    Citations:    Fields:    Translation:Humans
  10. Wang D, Lin M, Utz B, Bosompem A, Guo Y, Daneshbod Y, Alford CE, Nettles SA, Scher J, Gagne EY, O'Neill M, Barrow L, Wojciechowska N, Keegan J, Mosse CA, Lederer JA, Kim AS. miR-378-3p Knockdown Recapitulates Many of the Features of Myelodysplastic Syndromes. Am J Pathol. 2021 11; 191(11):2009-2022. PMID: 34364880.
    Citations:    Fields:    Translation:HumansCells
  11. Fitzpatrick MJ, Massoth LR, Marcus C, Vergilio JA, Severson E, Duncan D, Ramkissoon SH, Hasserjian RP, Kim AS, Sohani AR, Williams EA, Nardi V. JAK2 Rearrangements Are a Recurrent Alteration in CD30+ Systemic T-Cell Lymphomas With Anaplastic Morphology. Am J Surg Pathol. 2021 07 01; 45(7):895-904. PMID: 34105517.
    Citations: 4     Fields:    Translation:Humans
  12. Raman HS, Shanmugam V, Li J, Steensma DP, Kim AS, Luskin MR. NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation. Leuk Lymphoma. 2021 07; 62(7):1790-1792. PMID: 33586600.
    Citations:    Fields:    Translation:Humans
  13. Pozdnyakova O, Connell NT, Battinelli EM, Connors JM, Fell G, Kim AS. Clinical Significance of CBC and WBC Morphology in the Diagnosis and Clinical Course of COVID-19 Infection. Am J Clin Pathol. 2021 Feb 11; 155(3):364-375. PMID: 33269374.
    Citations: 12     Fields:    Translation:HumansCells
  14. Pikman Y, Tasian SK, Sulis ML, Stevenson K, Blonquist TM, Apsel Winger B, Cooper TM, Pauly M, Maloney KW, Burke MJ, Brown PA, Gossai N, McNeer JL, Shukla NN, Cole PD, Kahn JM, Chen J, Barth MJ, Magee JA, Gennarini L, Adhav AA, Clinton CM, Ocasio-Martinez N, Gotti G, Li Y, Lin S, Imamovic A, Tognon CE, Patel T, Faust HL, Contreras CF, Cremer A, Cortopassi WA, Garrido Ruiz D, Jacobson MP, Dharia NV, Su A, Robichaud AL, Saur Conway A, Tarlock K, Stieglitz E, Place AE, Puissant A, Hunger SP, Kim AS, Lindeman NI, Gore L, Janeway KA, Silverman LB, Tyner JW, Harris MH, Loh ML, Stegmaier K. Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory, or High-Risk Leukemias: A Report from the LEAP Consortium. Cancer Discov. 2021 06; 11(6):1424-1439. PMID: 33563661.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  15. Hergott CB, Dal Cin P, Hornick JL, Winer ES, Carrasco RD, Kim AS. Characteristic nuclear membrane ALK reactivity in chronic myelomonocytic leukemia with RANBP2-ALK fusion. Am J Hematol. 2021 Jan 25. PMID: 33491794.
    Citations:    Fields:    
  16. Bhatt S, Pioso MS, Olesinski EA, Yilma B, Ryan JA, Mashaka T, Leutz B, Adamia S, Zhu H, Kuang Y, Mogili A, Louissaint A, Bohl SR, Kim AS, Mehta AK, Sanghavi S, Wang Y, Morris E, Halilovic E, Paweletz CP, Weinstock DM, Garcia JS, Letai A. Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia. Cancer Cell. 2020 12 14; 38(6):872-890.e6. PMID: 33217342.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  17. Lucas F, Michaels PD, Wang D, Kim AS. Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing. Blood Adv. 2020 09 22; 4(18):4362-4365. PMID: 32926123.
    Citations: 2     Fields:    Translation:Humans
  18. Beck RC, Kim AS, Goswami RS, Weinberg OK, Yeung CCS, Ewalt MD. Molecular/Cytogenetic Education for Hematopathology Fellows. Am J Clin Pathol. 2020 07 07; 154(2):149-177. PMID: 32444878.
    Citations: 1     Fields:    Translation:Humans
  19. Tsai HK, Brackett DG, Szeto D, Frazier R, MacLeay A, Davineni P, Manning DK, Garcia E, Lindeman NI, Le LP, Lennerz JK, Gibson CJ, Lindsley RC, Kim AS, Nardi V. Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms. J Mol Diagn. 2020 09; 22(9):1162-1178. PMID: 32603763.
    Citations: 3     Fields:    Translation:HumansCells
  20. Luskin MR, Kim AS, Patel SS, Wright K, LeBoeuf NR, Lane AA. Evidence for separate transformation to acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm from a shared ancestral hematopoietic clone. Leuk Lymphoma. 2020 09; 61(9):2258-2261. PMID: 32366145.
    Citations: 2     Fields:    Translation:HumansCells
  21. Keegan A, Bridge JA, Lindeman NI, Long TA, Merker JD, Moncur JT, Montgomery ND, Nagarajan R, Rothberg PG, Routbort MJ, Vasalos P, Xian R, Kim AS. Proficiency Testing of Standardized Samples Shows High Interlaboratory Agreement for Clinical Next Generation Sequencing-Based Hematologic Malignancy Assays With Survey Material-Specific Differences in Variant Frequencies. Arch Pathol Lab Med. 2020 Jan 27. PMID: 31986076.
    Citations: 1     Fields:    
  22. Craig JW, Hasserjian RP, Kim AS, Aster JC, Pinkus GS, Hornick JL, Steensma DP, Coleman Lindsley R, DeAngelo DJ, Morgan EA. Detection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosis. Mod Pathol. 2020 06; 33(6):1135-1145. PMID: 31896808.
    Citations: 4     Fields:    Translation:Humans
  23. Shanmugam V, Parnes A, Kalyanaraman R, Morgan EA, Kim AS. Clinical utility of targeted next-generation sequencing-based screening of peripheral blood in the evaluation of cytopenias. Blood. 2019 12 12; 134(24):2222-2225. PMID: 31697812.
    Citations: 3     Fields:    Translation:HumansCells
  24. Khatri SS, Kim AS. Li-Fraumeni syndrome presenting as precursor B lymphoblastic leukemia mimicking intravascular large B-cell lymphoma. Blood. 2019 09 19; 134(12):993. PMID: 31537539.
    Citations:    Fields:    Translation:Humans
  25. Soma LA, Kovach AE, Siddon AJ, Beck R, Gibson SE, Swerdlow SH, Kim AS, Wu D, Jones D, Cook JR, Prakash S, Rosado F, Crane G, Bradley K, Weinberg OK, Sargent RL. Molecular and Cytogenetic Education in Hematopathology Fellowship. Am J Clin Pathol. 2019 09 09; 152(4):438-445. PMID: 31141139.
    Citations:    Fields:    Translation:Humans
  26. Moncur JT, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Kim AS. Performance Comparison of Different Analytic Methods in Proficiency Testing for Mutations in the BRAF, EGFR, and KRAS Genes: A Study of the College of American Pathologists Molecular Oncology Committee. Arch Pathol Lab Med. 2019 10; 143(10):1203-1211. PMID: 30969158.
    Citations: 1     Fields:    Translation:Humans
  27. Surrey LF, Oakley FD, Merker JD, Long TA, Vasalos P, Moncur JT, Kim AS. Next-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on BRAF, EGFR, and KRAS Proficiency Testing Samples. Arch Pathol Lab Med. 2019 08; 143(8):980-984. PMID: 30865489.
    Citations: 2     Fields:    Translation:Humans
  28. Olszewski AJ, Chorzalska AD, Kim AS, Quesenberry PJ, Lopresti ML, Fenton MA, Reagan JL, Butera JN, Sahin I, Hamel C, Robison J, Petersen M, Dubielecka PM. Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy. Br J Haematol. 2019 08; 186(3):e31-e35. PMID: 30859554.
    Citations: 3     Fields:    Translation:Humans
  29. Merker JD, Devereaux K, Iafrate AJ, Kamel-Reid S, Kim AS, Moncur JT, Montgomery SB, Nagarajan R, Portier BP, Routbort MJ, Smail C, Surrey LF, Vasalos P, Lazar AJ, Lindeman NI. Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays. Arch Pathol Lab Med. 2019 04; 143(4):463-471. PMID: 30376374.
    Citations: 12     Fields:    Translation:Humans
  30. McClure RF, Ewalt MD, Crow J, Temple-Smolkin RL, Pullambhatla M, Sargent R, Kim AS. Clinical Significance of DNA Variants in Chronic Myeloid Neoplasms: A Report of the Association for Molecular Pathology. J Mol Diagn. 2018 11; 20(6):717-737. PMID: 30138727.
    Citations: 11     Fields:    Translation:HumansCells
  31. Shanmugam V, Morgan EA, DeAngelo DJ, Kim AS. Many faces of the same myeloid neoplasm: a case of leukaemia cutis with mixed histiocytic and Langerhans cell differentiation. J Clin Pathol. 2019 01; 72(1):93-96. PMID: 30093508.
    Citations: 1     Fields:    Translation:HumansCells
  32. Kim AS, Bartley AN, Bridge JA, Kamel-Reid S, Lazar AJ, Lindeman NI, Long TA, Merker JD, Rai AJ, Rimm DL, Rothberg PG, Vasalos P, Moncur JT. Comparison of Laboratory-Developed Tests and FDA-Approved Assays for BRAF, EGFR, and KRAS Testing. JAMA Oncol. 2018 06 01; 4(6):838-841. PMID: 29242895.
    Citations: 11     Fields:    Translation:Humans
  33. Wheeler FC, Kim AS, Mosse CA, Shaver AC, Yenamandra A, Seegmiller AC. Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-up. Am J Clin Pathol. 2018 Mar 29; 149(5):418-424. PMID: 29538617.
    Citations:    Fields:    Translation:Humans
  34. Cortazar JM, Kim AS. Incidental Langerhans cell histiocytosis of the colon with BRAF p.V600E mutation. Blood. 2017 10 19; 130(16):1870. PMID: 29051154.
    Citations: 1     Fields:    Translation:Humans
  35. Wang-Rodriguez J, Yunes A, Phan R, Ma N, Baddoura F, Mosse C, Kim AS, Lu CM, Dong DZM, Schichman S, Icardi M, Ehsan A. The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA. Fed Pract. 2017 Aug; 34(Suppl 5):S50-S61. PMID: 30766310.
    Citations:    
  36. Çaliskaner ZO, Çakar T, Özçelik E, Özdilek A, Kim AS, Dogan Ö, Bosompem A, Grosveld G, Saka B, Kandilci A. DEK protein level is a biomarker of CD138positive normal and malignant plasma cells. PLoS One. 2017; 12(5):e0178025. PMID: 28558048.
    Citations: 1     Fields:    Translation:HumansCells
  37. Guo Y, Strickland SA, Mohan S, Li S, Bosompem A, Vickers KC, Zhao S, Sheng Q, Kim AS. MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia. Leuk Lymphoma. 2017 09; 58(9):1-15. PMID: 28084850.
    Citations: 14     Fields:    Translation:HumansCells
  38. Seegmiller AC, Kim AS, Mosse CA, Shaver AC, Thompson MA, Li S, Head DR, Zutter MM. Data-Driven Iterative Refinement of Bone Marrow Testing Protocols Leads to Progressive Improvement in Cytogenetic and Molecular Test Utilization. Am J Clin Pathol. 2016 Nov 01; 146(5):585-593. PMID: 27769956.
    Citations: 2     Fields:    Translation:HumansCells
  39. Andl CD, Le Bras GF, Loomans H, Kim AS, Zhou L, Zhang Y, Andl T. Association of TGFß signaling with the maintenance of a quiescent stem cell niche in human oral mucosa. Histochem Cell Biol. 2016 Nov; 146(5):539-555. PMID: 27480259.
    Citations: 4     Fields:    Translation:HumansCells
  40. Rosado FG, Rinker EB, Plummer WD, Dupont WD, Spradlin NM, Reichard KK, Kim AS. The diagnosis of adult-onset haemophagocytic lymphohistiocytosis: lessons learned from a review of 29 cases of bone marrow haemophagocytosis in two large academic institutions. J Clin Pathol. 2016 Sep; 69(9):805-9. PMID: 26896491.
    Citations: 1     Fields:    Translation:Humans
  41. Rinker EB, Dueber JC, Qualtieri J, Tedesco J, Erdogan B, Bosompem A, Kim AS. Differential expression of ribosomal proteins in myelodysplastic syndromes. J Clin Pathol. 2016 Feb; 69(2):176-80. PMID: 26408650.
    Citations: 2     Fields:    Translation:HumansCells
  42. Guo Y, Bosompem A, Mohan S, Erdogan B, Ye F, Vickers KC, Sheng Q, Zhao S, Li CI, Su PF, Jagasia M, Strickland SA, Griffiths EA, Kim AS. Transfer RNA detection by small RNA deep sequencing and disease association with myelodysplastic syndromes. BMC Genomics. 2015 Sep 24; 16:727. PMID: 26400237.
    Citations: 25     Fields:    Translation:HumansCells
  43. Wynn JL, Scumpia PO, Stocks BT, Romano-Keeler J, Alrifai MW, Liu JH, Kim AS, Alford CE, Matta P, Weitkamp JH, Moore DJ. Neonatal CD71+ Erythroid Cells Do Not Modify Murine Sepsis Mortality. J Immunol. 2015 Aug 01; 195(3):1064-70. PMID: 26101326.
    Citations: 11     Fields:    Translation:HumansAnimalsCells
  44. Smith MC, Kressin MK, Crawford E, Wang XJ, Kim AS. B Lymphoblastic Leukemia With a Novel t(11;15) (q23;q15) and Unique Burkittoid Morphologic and Immunophenotypic Findings in a 9-Year-Old Boy. Lab Med. 2015; 46(4):320-6. PMID: 26489677.
    Citations: 3     Fields:    Translation:Humans
  45. Douds JJ, Long DJ, Kim AS, Li S. Diagnostic and prognostic significance of CD200 expression and its stability in plasma cell myeloma. J Clin Pathol. 2014 Sep; 67(9):792-6. PMID: 24958785.
    Citations: 4     Fields:    Translation:HumansCells
  46. Shaver AC, Ma L, Vnencak-Jones C, Schwarting RS, Fasig KJ, Kim AS. Transformation of small B-cell lymphoma into large cell CD30?, CD4?, Epstein-Barr virus-negative lymphoma. Arch Pathol Lab Med. 2014 Aug; 138(8):1101-5. PMID: 25076300.
    Citations: 1     Fields:    Translation:Humans
  47. Ondrejka SL, Jegalian AG, Kim AS, Chabot-Richards DS, Giltnane J, Czuchlewski DR, Shetty S, Sekeres MA, Yenamandra A, Head D, Jagasia M, Hsi ED. PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin. Haematologica. 2014 Sep; 99(9):e148-51. PMID: 24951465.
    Citations: 1     Fields:    Translation:HumansCells
  48. Guo Y, Bosompem A, Zhong X, Clark T, Shyr Y, Kim AS. A comparison of microRNA sequencing reproducibility and noise reduction using mirVana and TRIzol isolation methods. Int J Comput Biol Drug Des. 2014; 7(2-3):102-12. PMID: 24878723.
    Citations: 6     Fields:    Translation:Humans
  49. Seegmiller AC, Kim AS, Mosse CA, Levy MA, Thompson MA, Kressin MK, Jagasia MH, Strickland SA, Reddy NM, Marx ER, Sinkfield KJ, Pollard HN, Plummer WD, Dupont WD, Shultz EK, Dittus RS, Stead WW, Santoro SA, Zutter MM. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Am J Clin Pathol. 2013 Nov; 140(5):643-50. PMID: 24124142.
    Citations: 6     Fields:    Translation:HumansCells
  50. Seegmiller AC, Wasserman A, Kim AS, Kressin MK, Marx ER, Zutter MM, Mosse CA. Limited utility of fluorescence in situ hybridization for common abnormalities of myelodysplastic syndrome at first presentation and follow-up of myeloid neoplasms. Leuk Lymphoma. 2014 Mar; 55(3):601-5. PMID: 23876099.
    Citations: 2     Fields:    Translation:Humans
  51. Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013 Jun; 139(6):713-27. PMID: 23690113.
    Citations: 104     Fields:    Translation:Humans
  52. Erdogan B, Bosompem A, Peng D, Han L, Smith E, Kennedy ME, Alford CE, Wu H, Zhao Z, Mosse CA, El-Rifai W, Kim AS. Methylation of promoters of microRNAs and their host genes in myelodysplastic syndromes. Leuk Lymphoma. 2013 Dec; 54(12):2720-7. PMID: 23547841.
    Citations: 5     Fields:    Translation:HumansCells
  53. Kressin MK, Kim AS. Metastatic Merkel cell carcinoma in the bone marrow of a patient with plasma cell myeloma and therapy-related myelodysplastic syndrome. Int J Clin Exp Pathol. 2012; 5(9):1007-12. PMID: 23119121.
    Citations: 3     Fields:    Translation:Humans
  54. Hart AJ, Jagasia MH, Kim AS, Mosse CA, Savani BN, Kassim A. Minimal residual disease in myeloma: are we there yet? Biol Blood Marrow Transplant. 2012 Dec; 18(12):1790-9. PMID: 22626785.
    Citations: 15     Fields:    Translation:Humans
  55. Kressin MK, Kim AS. Incidence of transient single metaphase chromosomal abnormalities identified by routine metaphase cytogenetics in bone marrow specimens. Leuk Lymphoma. 2012 Oct; 53(10):2080-2. PMID: 22452589.
    Citations:    Fields:    Translation:HumansCells
  56. Chmielecki J, Peifer M, Viale A, Hutchinson K, Giltnane J, Socci ND, Hollis CJ, Dean RS, Yenamandra A, Jagasia M, Kim AS, Davé UP, Thomas RK, Pao W. Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm. Genes Chromosomes Cancer. 2012 Jan; 51(1):54-65. PMID: 21938754.
    Citations: 8     Fields:    Translation:HumansCells
  57. Erdogan B, Facey C, Qualtieri J, Tedesco J, Rinker E, Isett RB, Tobias J, Baldwin DA, Thompson JE, Carroll M, Kim AS. Diagnostic microRNAs in myelodysplastic syndrome. Exp Hematol. 2011 Sep; 39(9):915-926.e2. PMID: 21703983.
    Citations: 26     Fields:    Translation:Humans
  58. Kim AS, Goldstein SC, Luger S, Van Deerlin VM, Bagg A. Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib? Am J Clin Pathol. 2008 Apr; 129(4):639-48. PMID: 18343792.
    Citations: 5     Fields:    Translation:Humans
  59. Bell IM, Stirdivant SM, Ahern J, Culberson JC, Darke PL, Dinsmore CJ, Drakas RA, Gallicchio SN, Graham SL, Heimbrook DC, Hall DL, Hua J, Kett NR, Kim AS, Kornienko M, Kuo LC, Munshi SK, Quigley AG, Reid JC, Trotter BW, Waxman LH, Williams TM, Zartman CB. Biochemical and structural characterization of a novel class of inhibitors of the type 1 insulin-like growth factor and insulin receptor kinases. Biochemistry. 2005 Jul 12; 44(27):9430-40. PMID: 15996097.
    Citations: 4     Fields:    Translation:HumansCells
  60. Peterson JR, Bickford LC, Morgan D, Kim AS, Ouerfelli O, Kirschner MW, Rosen MK. Chemical inhibition of N-WASP by stabilization of a native autoinhibited conformation. Nat Struct Mol Biol. 2004 Aug; 11(8):747-55. PMID: 15235593.
    Citations: 93     Fields:    Translation:AnimalsCells
  61. Kim AS. Clinical impact of gene expression profiling on oncology diagnosis, prognosis, and treatment. Comb Chem High Throughput Screen. 2004 May; 7(3):183-206. PMID: 15134525.
    Citations:    Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kim's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (280)
Explore
_
Co-Authors (67)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.